COO - COOPER COMPANIES, INC.

80.89
-1.690   -2.089%

Share volume: 1,150,372
Last Updated: 04-25-2025
Medical Equipment/Ophthalmic Goods: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$82.58
-1.69
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
93%
Profitability 100%
Dept financing 50%
Liquidity 75%
Performance 100%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.38%
1 Month
-4.81%
3 Months
-18.66%
6 Months
-23.33%
1 Year
-10.01%
2 Year
-14.44%
Key data
Stock price
$80.89
P/E Ratio 
61.19
DAY RANGE
$80.68 - $82.53
EPS 
$1.95
52 WEEK RANGE
$69.81 - $112.38
52 WEEK CHANGE
-$10.01
MARKET CAP 
19.270 B
YIELD 
N/A
SHARES OUTSTANDING 
199.156 M
DIVIDEND
$0.03
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-29-2025
BETA 
0.42
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,761,911
AVERAGE 30 VOLUME 
$2,039,466
Company detail
CEO: Albert G. White
Region: US
Website: coopercos.com
Employees: 14,000
IPO year: 1983
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing

CooperVision and CooperSurgical segments provide medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients. CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon.

Recent news
loading